Tuberculosis Vaccines for Domestic and Wildlife Species
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 261
Special Issue Editor
Special Issue Information
Dear Colleagues,
Tuberculosis is a zoonotic disease with a significant impact in Animal and Public Health. Tuberculosis in animals is worldwide distributed and eradication is difficult mainly due to the limited performance of the diagnostic tests, a complex epidemiology that includes a variety of domestic and wildlife reservoirs and finally, the absence of an effective vaccine to prevent the infection. Regarding the latter factor, the BCG vaccine is the only commercially available vaccine for humans and it has been used also in animals, alone or in combination with other experimental immunization strategies showing in general a limited performance preventing the infection although reducing the severity of lesions. Other vaccines have been developed in recent years or are currently under development and some of them have been evaluated in animals with promising results. An effective immunization against tuberculosis in animals would be of paramount importance to achieve the eradication of zoonotic tuberculosis and thus achieve the objective of eradicating human tuberculosis set by the WHO for the year 2050.
In this special issue is open to include original research manuscripts related to the development and evaluation of vaccines and strategies of immunization against tuberculosis in domestic and wildlife species that contribute to increasing knowledge in this field, favoring the control and eradication of tuberculosis in the future.
Prof. Dr. Javier Bezos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tuberculosis
- animals
- zoonosis
- vaccines
- vaccination
- control
- eradication
- immunology
